CYP1A2 (Tag Archives)
Subscribe to PricePlow's Newsletter and CYP1A2 Alerts
Why EuphoriQ: The Genetic Differences of Caffeine Metabolizers
In 2023, something really big happened. MuscleTech launched the EuphoriQ pre-workout — the first mass-market supplement containing paraxanthine, a stimulant that replaces (it’s actually the main metabolite of caffeine).
We brought Shawn Wells and Raza Bashir onto Episode #072 of the PricePlow Podcast to explain the story behind the ingredient (which is named “enfinity”[…]
Continue Reading →
Paraxanthine: Caffeine’s Major Metabolite for Laser-Targeted Energy
CAFFEINE.
A whopping 93% of American adults drink some sort of caffeinated beverage on a daily basis.[1]
So, we all pretty much love it, yet some of us hate it while loving it.
If you fall into the latter category, and have a tortured relationship with the western world’s drug of choice, read on, […]
Continue Reading →
September 25, 2023 Mike Roberto and
in Supplement Industry News, Supplement News, Supplement Research
| No Comments
